Literature DB >> 2947753

The cardiac hypertrophic responses to pathologic and physiologic loads.

J Scheuer, P Buttrick.   

Abstract

Myocardial hypertrophy is an adaptive response of the heart to an imposed load. Two distinct patterns of hypertrophy are discussed, pathologic and physiologic, which differ in their mechanical and biochemical features. Evidence is presented that supports the following hypotheses: the nature of the hypertrophy reflects the nature of the stimulus; the function of the hypertrophied heart reflects its biochemistry; and the degree of responsiveness of the heart varies with species and with age.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947753

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Endurance exercise training and treatment of hypertension. The controversy.

Authors:  R M Gilders; G A Dudley
Journal:  Sports Med       Date:  1992-02       Impact factor: 11.136

2.  Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth.

Authors:  Hanying Chen; Weidong Yong; Shuxun Ren; Weihua Shen; Yongzheng He; Karen A Cox; Wuqiang Zhu; Wei Li; Mark Soonpaa; R Mark Payne; Diego Franco; Loren J Field; Vicki Rosen; Yibin Wang; Weinian Shou
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

Review 3.  Effects of different antihypertensive drugs on left ventricular function.

Authors:  R Oliveri
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.

Authors:  E Kaplinsky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 5.  Molecular Mechanisms Underlying Cardiac Adaptation to Exercise.

Authors:  Rick B Vega; John P Konhilas; Daniel P Kelly; Leslie A Leinwand
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

Review 6.  Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.

Authors:  Sanford P Bishop; Jianyi Zhang; Lei Ye
Journal:  Biology (Basel)       Date:  2022-06-08

7.  Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Peter M Kang; Seigo Izumo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

8.  Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Adam L Dorfman; Sarah Longnus; Mario Pende; Kathleen A Martin; John Blenis; George Thomas; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  The correlation of cardiac mass with arterial haemodynamics of resistive and capacitive load in rats with normotension and established hypertension.

Authors:  C T Hu; K C Chang; T S Kuo; H I Chen
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.